FDA Inspection 1116380 — Evonik Corporation
The FDA completed an inspection of Evonik Corporation on Jan 16, 2020 in Lafayette, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 16, 2020
- Fiscal Year
- 2020
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Lafayette, IN (United States)